home / stock / bntx / bntx news


BNTX News and Press, BioNTech SE From 06/18/24

Stock Information

Company Name: BioNTech SE
Stock Symbol: BNTX
Market: NYSE
Website: biontech.de

Menu

BNTX BNTX Quote BNTX Short BNTX News BNTX Articles BNTX Message Board
Get BNTX Alerts

News, Short Squeeze, Breakout and More Instantly...

BNTX - Pfizer sued in Kansas over COVID-19 vaccine

2024-06-18 14:13:37 ET More on Pfizer Pfizer Stock: The Reversal Should Keep Going Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcrip...

BNTX - FDA places partial hold on study for MediLink, BioNTech cancer drug

2024-06-17 11:17:09 ET More on BioNTech BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical BioNTech SE 2024 Q1 - Results - Earnings Call Presentation BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript FDA recommends KP.2 strain be ...

BNTX - FDA recommends KP.2 strain be used in updated COVID-19 shots

2024-06-13 18:34:04 ET More on BioNTech, Moderna, etc. BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcar...

BNTX - BioNTech: Managements Wants 10 Oncology Drug Approvals By 2030, I'm Skeptical

2024-06-13 17:48:39 ET Summary BioNTech's revenue soared during the COVID era, but the company faces uncertainty with declining vaccine sales and plans for new oncology-focused products. The company is shifting focus to oncology programs, aiming for multiple late-stage trials and ...

BNTX - RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One

2024-06-11 21:30:00 ET Summary We purchased Maravai shares early in Q3 2023, increased position as stock price dropped, similar to experience with META in 2022. Maravai's subsidiaries, TriLink and Cygnus, play critical roles in NAP and BS segments, with unique assets and capabilit...

BNTX - FDA selects JN.1 variant for next COVID vaccine campaign

2024-06-07 12:11:30 ET More on BioNTech, Moderna, etc. Pfizer: Surging Cancer Rates Will Boost Revenues Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript) Pfizer: Too Early For A Turnaround Moderna mRNA candidate chosen for FDA rare...

BNTX - Novavax marketing application for COVID shot undergoes FDA review

2024-06-06 08:04:56 ET More on Sanofi, Novavax, etc. Novavax: Sanofi Partnership Revitalizes My Magnum Opus Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade) Bird flu death in Me...

BNTX - FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall

2024-06-05 16:30:31 ET More on vaccine makers Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe? COVID vaccine makers ready updated shots for fall immunization drive Pfizer data for breast cancer therapy sends Olema higher Moderna, Inc. (MRNA) M...

BNTX - COVID vaccine makers ready updated shots for fall immunization drive

2024-06-05 10:52:27 ET More on BioNTech, Moderna, etc. Moderna, Inc. (MRNA) Moderna Oncology Investor Event (Transcript) Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript) Pfizer: The Chart Looks Like A Bottom, But Is The Dividen...

BNTX - Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership

2024-06-02 03:00:00 ET Summary Suzhou MediLink partners with BioNTech to use its antibody-drug conjugate platform, receiving an upfront payment of $25 million and up to $1.8 billion in milestones. Asahi Kasei offers $1.1 billion to acquire Calliditas Therapeutics, aiming to expand...

Previous 10 Next 10